Literature DB >> 11799193

Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein.

Stephan Urban1, Philippe Gripon.   

Abstract

We have used the duck hepatitis B virus (DHBV) model to study the interference with infection by a myristoylated peptide representing an N-terminal pre-S subdomain of the large viral envelope protein. Although lacking the essential part of the carboxypeptidase D (formerly called gp180) receptor binding site, the peptide binds hepatocytes and subsequently blocks DHBV infection. Since its activity requires an amino acid sequence involved in host discrimination between DHBV and the related heron HBV (T. Ishikawa and D. Ganem, Proc. Natl. Acad. Sci. USA 92:6259-6263, 1995), we suggest that it is related to the postulated host-discriminating cofactor of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799193      PMCID: PMC135925          DOI: 10.1128/jvi.76.4.1986-1990.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction.

Authors:  S Urban; C Schwarz; U C Marx; H Zentgraf; H Schaller; G Multhaup
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  A soluble form of the avian hepatitis B virus receptor. Biochemical characterization and functional analysis of the receptor ligand complex.

Authors:  S Urban; C Kruse; G Multhaup
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

Review 3.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 4.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

5.  Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180.

Authors:  S Urban; K M Breiner; F Fehler; U Klingmüller; H Schaller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

7.  Isolation and characterization of a hepatitis B virus endemic in herons.

Authors:  R Sprengel; E F Kaleta; H Will
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

8.  Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.

Authors:  H J Schlicht; C Kuhn; B Guhr; R J Mattaliano; H Schaller
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

9.  Host cell-virus cross talk: phosphorylation of a hepatitis B virus envelope protein mediates intracellular signaling.

Authors:  K Rothmann; M Schnölzer; G Radziwill; E Hildt; K Moelling; H Schaller
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Myristylation of a duck hepatitis B virus envelope protein is essential for infectivity but not for virus assembly.

Authors:  D R Macrae; V Bruss; D Ganem
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

View more
  20 in total

Review 1.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  Hepatitis B virus morphogenesis.

Authors:  Volker Bruss
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 3.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.

Authors:  Severin Gudima; Anja Meier; Roland Dunbrack; John Taylor; Volker Bruss
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

Review 5.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

Review 6.  Emerging drugs for hepatitis B.

Authors:  Fabien Zoulim
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

7.  Screening for PreS specific binding ligands with a phage displayed peptides library.

Authors:  Qiang Deng; Ming Zhuang; Yu-Ying Kong; You-Hua Xie; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

8.  Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Authors:  Andreas Schulze; Alexa Schieck; Yi Ni; Walter Mier; Stephan Urban
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes.

Authors:  Azeneth Barrera; Bernadette Guerra; Helen Lee; Robert E Lanford
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.

Authors:  Guocai Zhong; Huan Yan; Haimin Wang; Wenhui He; Zhiyi Jing; Yonghe Qi; Liran Fu; Zhenchao Gao; Yi Huang; Guangwei Xu; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.